NCT02920528View on ClinicalTrials.gov

Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

June 22, 2018

Study Completion Date

September 1, 2019

Conditions
Chronic Pain
Interventions
DRUG

Ketamine

sub-dissociative ketamine

DRUG

Placebo

Normal Saline

Trial Locations (1)

90501

Emergency Department, Harbor-UCLA Medical Center, Torrance

All Listed Sponsors
collaborator

United States Air Force Research Laboratory

FED

lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

NCT02920528 - Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain | Biotech Hunter | Biotech Hunter